Central Trust Company’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Buy
32,888
+188
+0.6% +$69.7K 0.25% 73
2026
Q1
$8.85M Sell
32,700
-837
-2% -$249K 0.17% 93
2025
Q4
$11.1M Sell
33,537
-2,039
-6% -$691K 0.22% 78
2025
Q3
$12.3M Sell
35,576
-7,239
-17% -$2.19M 0.26% 67
2025
Q2
$13.4M Sell
42,815
-3,119
-7% -$1.19M 0.31% 61
2025
Q1
$24.1M Sell
45,934
-603
-1% -$308K 0.59% 39
2024
Q4
$23.5M Sell
46,537
-24,616
-35% -$14M 0.58% 39
2024
Q3
$41.6M Sell
71,153
-1,109
-2% -$627K 0.97% 25
2024
Q2
$36.8M Buy
72,262
+149
+0.2% +$73K 0.9% 29
2024
Q1
$35.7M Sell
72,113
-282
-0.4% -$143K 0.89% 27
2023
Q4
$38.1M Buy
72,395
+65
+0.1% +$34.7K 1.01% 24
2023
Q3
$36.5M Buy
72,330
+217
+0.3% +$107K 1.05% 21
2023
Q2
$34.7M Sell
72,113
-27
-0% -$13.2K 0.97% 23
2023
Q1
$34.1M Sell
72,140
-712
-1% -$344K 1% 23
2022
Q4
$38.6M Sell
72,852
-3,581
-5% -$1.9M 1.19% 17
2022
Q3
$38.6M Sell
76,433
-501
-0.7% -$263K 1.32% 15
2022
Q2
$39.5M Sell
76,934
-1,271
-2% -$638K 1.3% 15
2022
Q1
$39.9M Sell
78,205
-1,045
-1% -$504K 1.14% 20
2021
Q4
$39.8M Sell
79,250
-143
-0.2% -$64.7K 1.12% 18
2021
Q3
$31M Sell
79,393
-702
-0.9% -$291K 1.11% 15
2021
Q2
$32.1M Sell
80,095
-224
-0.3% -$89.3K 1.16% 14
2021
Q1
$29.9M Buy
80,319
+204
+0.3% +$70.7K 1.17% 17
2020
Q4
$28.1M Sell
80,115
-1,005
-1% -$337K 1.15% 18
2020
Q3
$25.3M Buy
81,120
+444
+0.6% +$136K 1.14% 18
2020
Q2
$23.8M Buy
80,676
+78
+0.1% +$22.4K 1.19% 14
2020
Q1
$20.1M Buy
80,598
+1,583
+2% +$436K 1.23% 17
2019
Q4
$23.2M Buy
79,015
+213
+0.3% +$55.7K 1.19% 16
2019
Q3
$17.1M Buy
78,802
+1,028
+1% +$248K 0.96% 25
2019
Q2
$20.3M Sell
77,774
-2,113
-3% -$508K 1.16% 21
2019
Q1
$19.8M Buy
79,887
+2
+0% +$510 1.18% 20
2018
Q4
$19.9M Buy
79,885
+835
+1% +$221K 1.32% 19
2018
Q3
$21M Buy
79,050
+1,718
+2% +$447K 1.22% 18
2018
Q2
$19M Sell
77,332
-363
-0.5% -$87.2K 1.21% 19
2018
Q1
$16.6M Buy
77,695
+1,351
+2% +$309K 1.06% 24
2017
Q4
$16.8M Buy
76,344
+279
+0.4% +$59.1K 1.02% 24
2017
Q3
$14.9M Sell
76,065
-3,085
-4% -$596K 0.96% 27
2017
Q2
$14.7M Buy
79,150
+1,551
+2% +$272K 0.97% 26
2017
Q1
$12.7M Buy
77,599
+2,043
+3% +$335K 0.85% 30
2016
Q4
$12.1M Buy
75,556
+7,201
+11% +$1.08M 0.83% 29
2016
Q3
$9.57M Sell
68,355
-646
-0.9% -$90.5K 0.7% 34
2016
Q2
$9.74M Buy
69,001
+8,832
+15% +$1.18M 0.73% 31
2016
Q1
$7.75M Sell
60,169
-594
-1% -$70.3K 0.61% 41
2015
Q4
$7.15M Sell
60,763
-2,189
-3% -$256K 0.59% 42
2015
Q3
$7.3M Sell
62,952
-575
-0.9% -$68.8K 0.64% 39
2015
Q2
$7.75M Buy
63,527
+1,517
+2% +$179K 0.61% 40
2015
Q1
$7.33M Buy
62,010
+189
+0.3% +$21K 0.59% 41
2014
Q4
$6.25M Sell
61,821
-8,259
-12% -$783K 0.51% 49
2014
Q3
$6.04M Sell
70,080
-518
-0.7% -$43.8K 0.48% 50
2014
Q2
$5.77M Buy
70,598
+822
+1% +$64.7K 0.45% 57
2014
Q1
$5.72M Buy
69,776
+2,407
+4% +$181K 0.47% 55
2013
Q4
$5.07M Sell
67,369
-4,238
-6% -$304K 0.43% 53
2013
Q3
$5.13M Sell
71,607
-224
-0.3% -$16K 0.46% 53
2013
Q2
$4.7M Buy
+71,831
New +$4.47M 0.45% 60

Other funds holding UNH

Central Trust Company's UNH Position: Q2 2026 in Review

Central Trust Company increased its UnitedHealth (UNH) stake by 0.57% in Q2 2026, buying an estimated $69.7K and bringing the position to 32,888 shares worth $13.7M. The position accounts for 0.25% of the portfolio, ranked #73.

Central Trust Company first reported a position in UNH in Q2 2013 and has held it in 53 quarters since. The position peaked at $41.6M in Q3 2024. 1,663 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Central Trust Company held 32,888 shares of UnitedHealth worth $13.7M as of Q2 2026.
  • Central Trust Company bought 188 UnitedHealth shares in Q2 2026, an estimated $69.7K.
  • UnitedHealth made up 0.25% of Central Trust Company's portfolio in Q2 2026, its #73 holding.
  • Central Trust Company first reported a position in UnitedHealth in Q2 2013 and has held it in 53 quarters since.
  • Central Trust Company's UnitedHealth position peaked at $41.6M in Q3 2024.
  • 1,663 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.